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Introduction: Development of non-invasive molecular imaging techniques that are based on cellular changes in
inflammation has been of active interest for arthritis diagnosis. This technology will allow real-time detection of
tissue damage and facilitate earlier treatment of the disease, thus representing an improvement over X-rays, which
detect bone damage at the advanced stage. Tracing apoptosis, an event occurring in inflammation, has been a
strategy used. PSVue 794 is a low-molecular-weight, near-infrared (NIR)-emitting complex of bis(zinc2+-dipicolylamine)
(Zn-DPA) that binds to phosphatidylserine (PS), a plasma membrane anionic phospholipid that becomes flipped
externally upon cell death by apoptosis. In this study, we evaluated the capacity of PSVue 794 to act as an in vivo
probe for non-invasive molecular imaging assessment of rheumatoid arthritis (RA) via metabolic function in murine
collagen-induced arthritis, a widely adopted animal model for RA.
Methods: Male DBA/1 strain mice were treated twice with chicken collagen type II in Freund’s adjuvant. Their
arthritis development was determined by measuring footpad thickness and confirmed with X-ray analysis and
histology. In vivo imaging was performed with the NIR dye and the LI-COR Odyssey Image System. The level of
emission was compared among mice with different disease severity, non-arthritic mice and arthritic mice injected
with a control dye without the Zn-DPA targeting moiety.
Results: Fluorescent emission correlated reliably with the degree of footpad swelling and the manifestation of
arthritis. Ex vivo examination showed emission was from the joint. Specificity of binding was confirmed by the
lack of emission when arthritic mice were given the control dye. Furthermore, the PS-binding protein annexin V
displaced the NIR dye from binding, and the difference in emission was numerically measurable on a scale.
Conclusions: This report introduces an economical alternative method for assessing arthritis non-invasively in
murine models. Inflammation in feet and ankles can be measured longitudinally using the PSVue 794 probe for
cell death and with a commonly available multipurpose imager. This technique provides metabolic and functional
information that anatomical measurement of footpad swelling or visual determination of arthritic index cannot.
It also may decrease the number of animals required per experiment because tissue damage will not necessarily
require evaluation by harvesting joints for histology.* Correspondence: marion.chan@temple.edu
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According to the American College of Rheumatology,
the autoimmune disease rheumatoid arthritis (RA) affects
1.3 million adults in the United States [1]. Currently,
standard diagnosis relies on clinical symptoms such as
tenderness, stiffness, swelling and pain. More objective
measurement has to wait for the disease to advance to
bone damage, which can be imaged by radiography [2]. As
disease-modifying drugs are most effective when used
early in the disease process, there is a need to develop
new techniques suitable for early imaging of arthritis in
real time. Magnetic resonance imaging detects earlier
stages of arthritis. However, it faces a challenge in diagnos-
ing synovitis (that is, inflammation of the membrane) in
the small-sized phalangeal joints [3]. In humans, a move-
ment to develop molecular imaging by metabolic changes
has begun following positive outcomes in animal models.
Targets and probes include protease activity, endothelial
activation, macrophage accumulation in the inflamed
joints and cell death [4-8]. The current status of mo-
lecular imaging of RA has been reviewed comprehen-
sively by Put et al. [9].
For RA, murine collagen-induced arthritis (CIA) is a
preclinical small-animal model that has been used rou-
tinely for designing and testing new therapies [10-15]. In
this model, arthritis is induced by immunization with
heterologous collagen to generate antigen–antibody com-
plexes that deposit on the joints. The chronic inflammatory
state presents as synovitis with features including cytokine
production, endothelial activation, neutrophil and macro-
phage infiltration, fibroblast hyperplasia and cartilage and
bone damage [14,16]. A counterbalancing proresolution
mechanism underlies the pathogenesis whereby apoptosis
of the immune activated cells leads to remission and ter-
mination of the inflammatory response [17]. The patho-
genic mechanisms and cellular dynamics during disease
onset and progression in mice have been characterized ex-
tensively and are regarded as similar to humans [18]. These
developments have increased our knowledge of the
immune reactions and metabolic pathways involved in
autoimmunity-induced injuries. Wide acceptance of the
CIA model is illustrated by the fact that JAX-West
(Sacramento, CA, USA), Charles River Laboratories
(Wilmington, MA, USA), MD Biosciences (St Paul, MN,
USA), Hooke Laboratories (Lawrence, MA, USA) and
Washington Biotechnology (Seattle, WA, USA) all offer
efficacy testing of commercial compounds for arthritis
based on this model. The standard readouts for disease
activity are anatomical: ankle and paw swelling over
time, clinical signs of inflammation (redness and stiff-
ness) and histological scoring of joint damage [11-13].
Cell proliferation and death are both intricate and
highly regulated steps in an inflammatory reaction [19].
At the height of inflammation, tissue damage leads tocell death. The immunoreactive cells are cleared by apop-
tosis as well [20,21]. For example, neutrophils are a class
of short-lived immunoreactive cells that infiltrate inflamed
sites in large numbers and die by apoptosis during its
resolution [22]. Detection of apoptosis is one of the novel
targets for visualizing functional changes at the cellular
level [2].
Phosphatidylserine (PS) is an anionic, negatively charged
phospholipid located internally within the cytoplasmic leaf-
let of the plasma membrane. It is a molecular marker of
cell death because it is externalized during apoptosis
[23,24]. The molecule then becomes a recognition signal
for phagocytic binding and removal of the expended cell.
Annexin V is a small protein (36 kDa in size) that binds to
PS and has been used as a standard marker for apoptosis
in vitro and in flow cytometry [25]. However, it has limita-
tions in vivo, where the microenvironment is more variable
and complex [26,27]. The search for alternate markers suit-
able for in vivo imaging of cell death continues.
Near-infrared (NIR) dyes are promising modalities for
non-invasive molecular imaging. PSVue®794 (hereafter
referred as PSVue®794; USA) is a low-molecular-weight
compound (1,837.6 g/mol) comprising a bis(zinc2+-dipico-
lylamine) (Zn-DPA) complex attached to a fluorescent dye
with an excitation maximum of 794 nm and an emission
maximum of 810 nm (Figure 1). Its photophysical proper-
ties, spectra and quantum yield, absorption and emission
curves, are available in the supplementary material in the
publication by Leevy et al. [28]. PSVue 794 binds to anionic
phospholipids, including PS, by the Zn-DPA targeting moi-
ety and thus can be used as a marker of cell death, both
apoptotic and necrotic [29]. In fact, the zinc coordination
complex has been documented to distinguish dead and
dying mammalian cells from live ones in vitro and in vivo.
In vitro, it co-localizes with annexin V in Jurkat cells that
are induced for apoptosis, but not in live cells [29,30]. It
also co-localizes with propidium iodide in murine hip-
pocampal HT22 cells induced for cell death, but not in
healthy cells [31]. In vivo, its binding to anionic phos-
pholipids on apoptotic cells has been demonstrated with
tumors killed with the tyrosine kinase inhibitor suniti-
nib [32] and in thymi from dexamethasone-treated rats
[33]. Interestingly, PSVue 794 also binds to bacteria
with anionic phospholipids, such as Staphylococcus
aureus and Escherichia coli [28 and supplementary
material therein].
PSVue 794 exhibits fluorescence at the NIR region,
where tissue absorption and non-specific backgrounds
are low [28]. For in vivo imaging, biodistribution studies
in rodent models have shown that intravenously admin-
istered molecules accumulate in the liver and kidney
when unbound and are cleared from the system within
48 hours [30,33]. Intravenously injected dye labels epi-
dermal carcinoma xenografted into nude mice treated
Figure 1 Chemical structure of PSVue 794.
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Its selectivity has been established with a non-specific
control probe that contains the same fluorophore, but
without the Zn-DPA targeting moiety [32]. Zn-DPA, with
various labels, has been used for in vivo imaging of apop-
totic and necrotic regions in liver, thymus, mammary and
prostate tumors, cerebral artery occlusion and acute cell
death conditions in rodents [29-34].
In the present study, we evaluated whether the cell
death targeting properties of PSVue 794 could be used
to non-invasively visualize the degree of autoimmune-
mediated inflammation in the murine CIA model in vivo.
The method described here correlates with anatomical
changes and allows semiquantitative comparison using an
economical fluorescence imager that is commonly avail-
able in most laboratories.
Methods
Induction of arthritis
The experimental protocol used in this study was ap-
proved by the Temple University Institutional Animal
Care and Use Committee. RA was induced in 6- to 8-
week-old male DBA/1 mice (The Jackson Laboratory,
Bar Harbor, ME, USA) with 50 μg of chicken type II
collagen (Chondrex, Redmond, WA, USA) emulsified in
complete Freund’s adjuvant and injected into the tail
base. The reaction was then boosted with another injec-
tion of 50 μg of the collagen in incomplete Freund’s ad-
juvant on day 21 [11]. Varying by the individual mouse,arthritis developed between day 40 and day 55 in 70% to
80% of the immunized animals. Disease development
was defined by footpad swelling and histology. Footpad
thickness was measured with a pressure tension caliper
in a double-blinded manner to follow the course of in-
flammation. Arthritis severity was defined by scoring the
increase in thickness of the hind footpads, calculated as
(thickness at day of measurement minus thickness prior
to immunization at day 0) divided by (thickness prior to
immunization at day 0). A mouse was considered as arth-
ritic when one of its four footpads had swollen and a hind
footpad thickness had increased by 15%. At the end of the
experiment, the limbs were harvested for X-ray analysis
using a Faxitron for small animals (model 43855; Faxitron
Bioptics, Tucson, AZ, USA) and exposed to 35 V for 12
seconds. In addition, the footpads were fixed in 10%
neutral buffered formalin, decalcified in 10% ethylenedi-
aminetetraacetic acid, embedded in paraffin, cut into serial
sections, stained with hematoxylin and eosin (H&E) and
evaluated for tissue destruction, cell infiltration and over-
all morphology as described by Chan and Moore [17].
Preparation of PSVue 794 and control dye
The PSVue 794 reagent kit was obtained from Molecular
Targeting Technologies, Inc. (West Chester, PA, USA). The
dye was prepared according to the manufacturer’s instruc-
tions. Briefly, the apo-PSVue 794 powder was dissolved in
the supplied diluent to a final concentration of 2 mM solu-
tion, which was mixed with an equal volume of 4.2 mM
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37°C to 40°C before use. The control dye, also from Mo-
lecular Targeting Technologies, contains the exact same
fluorophore but lacks the Zn-DPA targeting moiety.
The compound exhibits fluorescence at the NIR region,
with an excitation maximum of 787 nm and an emission
maximum of 808 nm. It was prepared for injection in
the same manner as PSVue 794 [32].
Preparation of mice for imaging
Mice that had developed arthritis were put on a low-
fluorescence AIN-76 diet for 4 to 6 days, and the fur on
their legs was removed with Nair (Church & Dwight,
Ewing, NJ, USA) approximately 16 hours prior to in vivo
imaging analysis. Unbound dye is cleared through urin-
ation, and the dye may be tracked on the fur. Freshly
prepared 1 mM experimental or control dye was admin-
istered, in excess, by retro-orbital injection at a volume
at 30 μl (about 2.2 μg/g body weight) per mouse [35]. A
clearance study was performed by scanning the mice
injected with the dye prior to injection and 20 minutes,
24 hours and 48 hours after injection. The unbound dye
was allowed 48 hours to clear out of the circulation.
Additional imaging was performed after 24 hours to en-
sure that the unbound dye had been completely cleared
during the scan.
A competition between PSVue 794 and annexin V (BD
Biosciences, San Jose, CA, USA) was also investigated by
NIR imaging. To determine whether the PSVue dye was
detecting apoptotic cells in the arthritic joints, a dis-
placement study was performed in vivo with annexin V.
Immunized mice first received an injection with PSVue
794 dye as described above, and the unbound dye was
allowed to clear. On the third day after dye injection, the
mice were first scanned to ensure retention of the fluor-
escent signal, and then 63 μg of annexin V was injected
retro-orbitally. After the annexin V injection, the mice
were scanned at hourly intervals to determine whether
there was displacement of the bound PSVue 794 dye.
With another set of immunized mice, the two reagents
were given in a reversed order. Annexin V protein was ad-
ministered retro-orbitally into mice 30 minutes prior to
PSVue dye. The mice were then scanned on the next day.
Imaging
PSVue 794 binding was measured using the LI-COR
Odyssey Image System for NIR emission, as instructed
in the application protocol manual [36]. Mice were anes-
thetized by intraperitoneal (IP) injection of a mixture of
ketamine (100 mg/kg) and xylazine (5 mg/kg) and placed
in the accessory mouse port to keep them at 37°C for
scanning. The instrument illuminated at two wavelengths,
700 and 800 nm, and emission fluorescence at 800 nm
was collected for analysis. Rectangular areas that coveredfrom the nose to the base of the tail were boxed for
scanning. Images were acquired either in 3.5 minutes at
169-μm resolution or in 7 minutes at 337 μm resolution
to balance image quality, scan speed and anesthetic limits
(less than 10 minutes).
A shaved area close to the region of interest (ROI) was
used to set the degree of background autofluorescence
for the normalization of each mouse and for the semi-
quantitative comparison of different experimental sub-
jects. The intensities (counts) registered at the 800-nm
wavelength were mapped to a color palette for pseudo-
color visual display using the Odyssey Application Soft-
ware version 3.0. The maximum intensity was set at
4,012 and the gamma value was set at 1 for distributing
the color in the pseudo-color image.
Results
Correspondence between dye binding and arthritic limbs
The pathogenesis of CIA follows three phases: induction,
progression and resolution [17]. There is a latency period
when the induced mice are asymptomatic, then the thick-
ness of the footpads progressively increases. The swelling
reaches a maximum and then begins to subside. In a par-
ticular immunization, the group of mice, though similar,
has individual variations in latency period as well as in the
degree of severity. The manifestation in the hind limbs
can be unilateral or bilateral. There are also mice whose
hind footpads have not swollen by more than 15% and are
considered as non-responders. Morphological and histo-
logical details of this CIA model have been presented pre-
viously [17]. These differences within a group provide a
spectrum of severity for evaluating whether PSVue 794
can be a useful molecular imaging probe for arthritis de-
velopment. In this study, a total of 34 mice were assigned
into groups according to whether none, one or both of
their hind footpads had swollen by 15%, with a minimum
of 3 per group, and analyzed. The development of arthritis
was confirmed with radiography, which displayed a loss
of bone density and joint misalignment, and H&E histo-
logical staining, which additionally showed hyperplasia
and necrosis (Figure 2).
Targeting specificity of PSVue 794 for the in vivo assay
was examined in a clearance study (Figure 3). The arth-
ritic mice, with footpads swollen by 45% to 50% in thick-
ness, were administered either the NIR dye or a control
dye that contains the same fluorophore, but without the
targeting moiety [32]. Prior to probe injection, emission
was at a background level due to autofluorescence. Im-
mediately after intravenous injection of the NIR dye, the
level of emission fluorescence was high in the feet and
distributed diffusely throughout the whole body. By 24
to 48 hours, excess dye was cleared, and fluorescence was
observed only in the legs, where the dye molecule had
bound. The legs of the mouse that received the control
Figure 2 Morphological characterization of arthritic footpad. Shown are comparisons of the typical morphology of normal (n = 14) and
arthritic (n = 34) footpads. (A) Photographs of typical normal and swollen arthritic footpads. The green rods serve as a reference for standardizing
the magnification. The black lines on the green rods are 2-cm scale bars. (B) X-rays of a normal and a representative arthritic foot. In the latter,
the image at right shows soft tissue swelling (arrow) and bone destruction at the ankle as well as loss of bone density and misalignment at the
metatarsophalangeal joints (arrowhead). (C) Hematoxylin and eosin staining of normal and arthritic animal thin sections. In the latter, the image
at right shows bone damage (arrows), cellular infiltrates and soft tissue swelling (arrowheads). Original magnification, ×40. (D) A necrotic focus
(arrow) adjacent to a bony area within the arthritic joint. Original magnification, ×400.
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arthritis could be detected only in the presence of Zn-
DPA targeting moiety. These results are in agreement with
previous reports [32,34].
The mice were evaluated to determine whether NIR
dye binding correlated with arthritis manifestation, as
assessed by footpad swelling. The dye provided a semi-
quantitative marker in correspondence with footpad swell-
ing, as shown in the representative examples in Figure 4.
In a mouse whose hind footpads were bilaterally affected,
emission was detected in both the left and right limbs. In
mice with unilateral manifestation in their hind footpads,
emission occurred only in the limbs with arthritis.
Emission was not seen in the contralateral limbs, ones
with swelling below 10%. In mice with resolved inflam-
mation, as well as the non-responder mice, emission
was not detected. It was at the level of background or
autofluorescence.Displacement and blocking of PSVue 794 by annexin V
Next, to determine whether the NIR dye was detecting
apoptotic cells in the arthritic joints, a displacement study
was performed in vivo with annexin V (Figure 5). After
unbound PSVue 794 had been cleared for 3 days, injection
of annexin V led to decease in emission, suggesting that
there was a displacement of the PSVue 794 that had been
bound to anionic phospholipids. Numerical comparison
was performed in two ROIs using the data from three dif-
ferent scans in which the mouse was repositioned. A sta-
tistically significant (P ≤ 0.05) reduction of NIR emission
was observed at 3 hours after annexin V administration.
Before injection of annexin V, the ROI at the toes had a K
count of 57.6 ± 3.5 and average intensity of 1,385 ± 86.
The ROI at the thigh region had a K count of 58.4 ± 7.0
and average intensity of 2,421 ± 252 (Figure 5A). Three
hours after injection of annexin V, the K count of the
ROI at the toes had decreased to 40.1 + 3.3 and average
Figure 3 Clearance study and specificity controls. Mice were induced for arthritis, and they developed footpad swelling at the level of a
45% to 50% increase in thickness. They were put on an AIN-76A diet for 4 to 6 days and then given 30 μl of 1 mM freshly prepared PSVue 794
(n = 24) or control dye (n = 3) retro-orbitally, as described in the text. The images shown were obtained using the LI-COR Odyssey Infrared
Imaging System at the times indicated. The arrows point to the presence or absence of signals in mouse feet using the near-infrared dye and
the control dye. The fur at the abdomen of the mice injected with the control dye had not been removed and was contaminated with unbound
dye excreted in urine.
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thigh was reduced to 42.39 ± 2.1 and average intensity
to 1,999 ± 83 (Figure 5B). So, annexin V reduced PSVue
794 binding by approximately 30%. When the two re-
agents were given in a reversed order, emission was
non-detectable (Figure 5C). It is likely that PSVue794,
as a small molecule, could not bind when the PS on the
cellular membrane had become covered by a larger pro-
tein. Annexin V complexes with PS via hydrophobic do-
mains [37]. PSVue 794 binds by electrostatic forces to
membrane surfaces enriched with PS [29].
Binding of the NIR dye was also demonstrated ex vivo.
A swollen foot was amputated, and its skin was removed
and then scanned. The emission was retained, ensuringthat fluorescence was internal (that is, from the inside).
A portion of its draining inguinal lymph node also showed
some degree of fluorescence, suggesting the presence of
vascular destruction and cell death in the organ. On the
contrary, emission was not detected in a similar foot la-
beled with the control dye (Figure 6).
Discussion
Arthritis is a complex family of musculoskeletal disor-
ders consisting of more than 100 different diseases or
conditions that destroy joints, bones, muscles, cartilage
and other connective tissues that hamper or halt physical
movement. Among them, RA, triggered by autoimmunity,
is one of the most common and the most disabling. This
Figure 4 (See legend on next page.)
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Figure 4 Correspondence between PSVue 794 near-infrared emission and arthritic footpad swelling. Mice (n = 34) were induced for
arthritis, and hind footpad swelling was followed for 50 to 60 days, as indicated in the line graphs. During the last week of the experiments, the
mice were put on an AIN-76A diet for 4 to 6 days and then given 30 μl of 1 mM freshly prepared PSVue 794 retro-orbitally. The images were
obtained using the LI-COR Odyssey Infrared Imaging System at 48 hours after PSVue 794 administration. The arrows point to the affected feet.
(A) A representative mouse with arthritis in both hind feet, swollen by more than 30%, when the image was taken. High fluorescence intensity
(red) was detected bilaterally. (B) and (C) Representative mice with unilateral arthritis in the left or right foot. High fluorescence intensity was
detected in the corresponding affected foot. (D), (E) and (F) show the lack of PSVue 794 near-infrared emission. (D) A mouse in which inflammation
increased in the right footpad but then subsided. (E) A non-responder that did not develop arthritis after immunization. (F) A representative
unimmunized mouse (n = 10).
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posed anionic phospholipid PS, provides a cost-effective
way to measure inflammation by apoptosis in a murine
arthritis model.
Apoptosis is a regulated function in the pathogenesis of
arthritis, and annexin V is well recognized as specific for
PS and applicable in imaging of apoptosis [38]. Apoptosis
occurs when inflammation begins to resolve. If this reso-
lution is obstructed, cell death perpetuates and chronic in-
flammatory diseases develop. In humans, 99mTc-annexin
can be used to visualize arthritic joints and detect onset of
bone destruction. Post et al. [8] used 99mTc-annexin V and
autoradiography to study the extent and severity of apop-
tosis in the front and rear paws of DBA/1 mice with CIA.Figure 5 Displacement and blocking between PSVue 794 and annexin
(n = 3) whose PSVue 794 dye had been allowed to clear for 3 days before
after injection of 63 μg of annexin V. After normalization for background, fluo
the toes and the thigh, indicated by arrows in (A) and (B)) were compared w
average from three scans by analysis of variance. (C) When 21 μg of annexin
swollen 40%, subsequent injection of PSVue 794, as described in the text, didOur present study reveals that PSVue 794 mimics the
apoptosis-sensing function of annexin V. The dye detects
inflammation-associated cell death and works as a probe
for non-invasive measurement of arthritis. We also show
that the level of emission reflects the degree of disease
manifestation in parallel with footpad swelling, a trad-
itional anatomical parameter that requires double-blind
measurement because it is more prone to human subject-
ivity. The difference in fluorescence emission between
mice can be compared objectively and semiquantitatively
based on a scale of emission. Control studies show that
the levels of emission in arthritic mice given the dye with-
out the PS targeting moiety, or in non-arthritic mice given
the dye, are substantially lower than in the experimentalV. (A) Fluorescence in the hind leg region of a representative mouse
administration of annexin V. (B) The signal was reduced at 3 hours
rescence emission (K counts and intensity) in the ROIs (circumscribed at
ith the LI-COR Odyssey Infrared Imaging System software, using the
V were administered in vivo into a mouse (n = 5) whose footpad was
not result in binding, and the dye was rapidly cleared.
Figure 6 Ex vivo imaging. (A) Skin was removed from an amputated arthritic foot in which thickness had increased by 29% (n = 6). High
intensity of near-infrared emission was detected in the pseudo-colored image, thus validating that the fluorescence was due to cell death at
the swollen ankle rather than to dye tracked externally on the foot. (B) Detection of apoptosis in portion of the associated inguinal lymph node.
(C) Lack of emission in a deskinned arthritic limb from a mouse injected with the control dye (n = 3).
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to the best of our knowledge, validates the selectivity of
binding of PSVue 794 directly by demonstrating that it in-
terferes with annexin V binding and vice versa. Previous
in vitro and ex vivo studies have shown only that the dye
and annexin binding co-localize [29,30].
Tissue penetration is a hindering factor in fluorescence
imaging. This problem is further complicated by the fact
that the vasculature is often compromised by vasculitis
in inflammatory autoimmune diseases. PSVue 794 has a
low molecular weight, so it can distribute through the
circulation with less hindrance than the larger annexin
V. Although a direct comparison between the two mole-
cules has yet to be demonstrated in the current arthritis
model, the NIR dye has been shown to label human epi-
dermoid carcinoma xenografts with broken blood vessels
more efficiently than annexin V [27,32]. Thus, it is likely
that a smaller dye molecule would have an advantage
over annexin V for imaging inflammatory diseases. A
factor underlying this success is that the dye emits in the
NIR region, where tissue absorption and scattering are
less than visible light. This non-invasive in vivo imaging
provides a means by which to follow the course of in-
flammation in real time and may allow investigators to
study animals longitudinally without the need to kill
them, thus reducing the number of animals required for
sequential time point analyses.The present study was done using an economical
imaging system widely used and present in many labora-
tories—the Odyssey Infrared Imaging System—because
arthritis is manifested in the footpads. Thus, the method
is affordable for most investigators. In addition to the
800-nm fluorescence intensity utilized in this study, the
instrument detects fluorescent dye that emits at 700 nm,
thus allowing investigators a range of choices, such as
prelabeled markers and dual labeling. The mice were
scanned with the mouse port accessory (MousePOD; LI-
COR Biosciences), and the emitted fluorescent photons
in affected limbs of small animals were counted. Other
imaging systems, such as Kodak Image Station 4000
(Eastman Kodak, Rochester, NY, USA), which uses white
light and filters, have also been used in conjunction with
PSVue 794 [39].
In this study, we performed the scanning without the
use of an inhalation anesthesia vaporizer system, further
reducing the cost. The scanning was done at 169 μm to
accommodate the anesthetic time limits (less than 10 mi-
nutes) attained by IP injection of ketamine and xylazine.
An anesthetic vaporizer system can be added to lengthen
the time for which the mouse can remain motionless, then
the scanning can be done at shorter intervals. For those
investigators who specialize in in vivo imaging of small an-
imals, instruments such as the LI-COR Pearl Impulse de-
tector may be used. This equipment’s scan speed can be
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of mice in a short period of time. In addition, imaging can
be done in other models of inflammation where the
inflicted organ is internal, such as when apoptosis occurs
in internal organs (for example, the brain) [31].
Extending from animal models, the PSVue molecule
may be further developed for diagnosis in humans, as
annexin V–based apoptosis imaging has produced en-
couraging results for assessment of chemo- or radiother-
apy. Radiolabeling the Zn-DPA targeting moiety with 18F
and 64Cu for positron emission tomography and 99mTc
and 111In for single-photon emission computed tomog-
raphy may circumvent the challenges caused by fluores-
cent signals being attenuated in vivo.
Conclusions
The PS-binding PSVue 794 dye was shown to be capable
of measuring arthritis in a rodent model (murine CIA).
This fast, sensitive and cost-effective technique may be
adaptable for clinical application in patients with RA.
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